Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2010
10/26/2010US7820619 potentiate antimicrobial functions of leukocytes such as neutrophils; lower inherent mammalian cell toxicities, improved immunogenicity and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum; antibiotic resistance; pharmacokinetics
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820390 Methods of and kits and compositions for diagnosing colorectal tumors
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010121023A2 Peptides and aptamers for targeting of neuron or nerves
10/21/2010WO2010121013A2 Molecularly imprinted polymers for detecting hiv-1
10/21/2010WO2010119583A1 Polymer-nucleic acid complex, method for imaging tumor cells or the like using same, and pharmaceutical composition for treatment of cancer
10/21/2010WO2010119192A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
10/21/2010WO2010119191A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
10/21/2010WO2010118547A1 Protein for the immunocastration for mammals
10/21/2010WO2010118521A1 Peptide ligands for clusterin and uses thereof
10/21/2010WO2010099472A3 Spanx-b polypeptides and their use
10/21/2010WO2010065815A3 Mini-hepcidin peptides and methods of using thereof
10/21/2010WO2009111273A3 Peptide targeting imaging agents and methods of use thereof
10/21/2010US20100267928 Activatable diagnostic and therapeutic compound
10/21/2010US20100267927 Structure of the Insulin Receptor Ectodomain
10/21/2010US20100267651 T cell antigen receptor peptides
10/21/2010US20100267650 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs
10/21/2010US20100267628 Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267621 Antimicrobial Compounds and Formulations
10/21/2010US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof
10/21/2010US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin
10/21/2010US20100267005 Crosslinking Within Coordination Complexes
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266557 Novel peptide-based scaffolds for cartilage regeneration and methods for their use
10/21/2010US20100266508 Stabilized gold nanoparticle and contrast agent
10/21/2010CA2756570A1 Peptide ligands for clusterin and uses thereof
10/21/2010CA2669470A1 Assay for detecting cathepsin k activity in bone, cartilage and/or soft tissue
10/20/2010EP2241573A2 Peptide derivatives and cosmetic composition comprising the same
10/20/2010EP2240770A1 Methods for detection of cyclosporin a
10/20/2010EP2240604A2 Peptides and methods of use as therapeutics and screening agents
10/20/2010EP2240507A2 Processes for preparing high purity aza cyclohexapeptides
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010CN101863971A Metastin derivatives and use thereof
10/20/2010CN101863965A Helicobacter pylori urease B antigenic epitope polypeptide and application thereof
10/20/2010CN101863964A Helicobacter pylori urease B antigen epitope polypeptide and application thereof
10/20/2010CN101863963A Helicobacter pylori antigen epitope polypeptide and application thereof
10/20/2010CN101863962A Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof
10/20/2010CN101863961A Preparation method of octreotide
10/20/2010CN101863960A Preparation method of cetrorelix
10/20/2010CN101863958A Induction of the mitochondrial permeability transition
10/20/2010CN101225106B Short peptide suppressing growth of cancer cell and uses thereof
10/19/2010US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT
10/19/2010US7816489 Methods for making intermediates and oxytocin analogues
10/19/2010US7816325 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV
10/19/2010CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
10/19/2010CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
10/19/2010CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010117997A2 Peptide targeting of inner ear cells
10/14/2010WO2010117753A2 Peptide compositions for oral care systems
10/14/2010WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η
10/14/2010WO2010116752A1 Neuromedin u derivative
10/14/2010WO2010115916A1 Process for isolating therapeutic peptide
10/14/2010WO2010074433A3 Novel bacteriophage and antibacterial composition comprising same
10/14/2010WO2010042548A9 Methods of treating inflammation
10/14/2010US20100261877 Process for isolating therapeutic peptides
10/14/2010US20100261876 Novel methods of synthesis for therapeutic antiviral peptides
10/14/2010US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/14/2010US20100261658 Peptide for activating aquaporin synthesis
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100261638 Lantibiotic-based compounds having antimicrobial activity
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261206 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
10/14/2010US20100260817 Polyamine Derivatives
10/14/2010US20100260791 Chlamydia antigens
10/14/2010US20100260790 S. Pneumoniae Antigens
10/14/2010US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010CA2758264A1 Neuromedin u derivative
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2239267A1 Tag peptide and use thereof
10/13/2010CN101861334A Cyclic receptor-associated protein (RAP) peptides
10/13/2010CN101861330A Polypeptide compound
10/13/2010CN101861329A Peptides as antimicrobial agents towards campylobacter spp
10/13/2010CN101861160A Antagonists of kisspeptin and uses thereof
10/13/2010CN101857632A Preparation and use of fatty acyl glycyl glycyl histidine-copper (II) complexes
10/13/2010CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/13/2010CN101857630A Fluorouracil derivative containing tyrosine-isoleucine-glycine-serine-arginine polypeptide
10/13/2010CN101857629A Solid-phase synthesis method of Bremelanotide
10/13/2010CN101190939B Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application
10/12/2010US7812118 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
10/12/2010US7811995 Therapeutic and diagnostic peptides
10/12/2010US7811993 BRAFV600E-based peptide mutants that induce major histocompatibility complex (MHC) Class I-dependent cytotoxic T cell responses provide prophylactic, diagnosis and therapeutic treatments; anticarcinogenic agents; drug development for non-peptide mimetics and in development of antibodies, vaccines
10/12/2010US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811828 Method for identifying and quantifying of tumuor-associated
10/12/2010US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/12/2010CA2497287C Method of humanizing immune system molecules
10/07/2010WO2010115080A2 Self-assembling peptides bearing organic electronic functionality and applications employing the same
10/07/2010WO2010115052A2 Induced pluripotent stem cells
10/07/2010WO2010114185A1 Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis
10/07/2010WO2010113753A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
10/07/2010WO2010113495A1 C6orf167 peptides and vaccines containing the same
10/07/2010WO2010113042A1 Antimicrobial cyclic peptides